Susquehanna raised the firm’s price target on Viavi (VIAV) to $65 from $25 and keeps a Positive rating on the shares. The firm Increased estimates across the board to reflect NSE revenue CAGR of 25%, with NSE accounting for 80% of total revenue by FY28. The OSE segment is expected to grow at a more modest 10% CAGR, representing 20% of the revenue mix.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIAV:
- Closing Bell Movers: Meta falls 6%, Alphabet jumps 6% after earnings
- Viavi reports Q3 adjusted EPS 27c, consensus 23c
- Viavi sees Q4 adjusted EPS 29c-31c, consensus 24c
- Viavi options imply 13.7% move in share price post-earnings
- Viavi announces investment in PCIe 7.0 protocol analysis testing platform